IMCD (OTCMKTS:IMCDY) Short Interest Update

IMCD (OTCMKTS:IMCDYGet Free Report) was the recipient of a significant decline in short interest in August. As of August 14th, there was short interest totaling 11,155 shares, a decline of 85.7% from the July 30th total of 78,045 shares. Based on an average daily trading volume, of 120,767 shares, the short-interest ratio is presently 0.1 days.

IMCD Stock Performance

Shares of IMCD stock traded down $0.30 during midday trading on Thursday, reaching $56.34. The company had a trading volume of 1,050 shares, compared to its average volume of 66,068. The stock has a fifty day simple moving average of $51.67 and a 200 day simple moving average of $51.27. IMCD has a 1-year low of $39.76 and a 1-year high of $61.56.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of IMCD in a research note on Thursday, July 30th. UBS Group upgraded shares of IMCD to a “buy” rating in a research note on Tuesday, July 14th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $72.50.

Read Our Latest Research Report on IMCDY

About IMCD

(Get Free Report)

IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company provides adhesives, core materials, filler reinforcements, flame retardants, masterbatch, modifiers, operating materials, pigments, plasticizers, processing aids, PUR raw materials, rubber elastomers, solvents, stabilizers, thermoplastic elastomers, thermoplastics, thermoplastics, and other additives.

Recommended Stories

Receive News & Ratings for IMCD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMCD and related companies with MarketBeat.com's FREE daily email newsletter.